D
Pfizer Inc. PFE
$22.28 -$0.26-1.15% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/30/2025 12/31/2024 09/29/2024 06/30/2024 03/31/2024
Revenue 11.65% 6.84% -12.76% -28.30% -39.94%
Total Other Revenue -- -45.30% -4.58% -4.63% -4.58%
Total Revenue 11.65% 6.84% -12.76% -28.31% -39.94%
Cost of Revenue -0.66% -7.72% -55.19% -32.39% -44.33%
Gross Profit 16.61% 13.04% 13.04% -26.58% -37.97%
SG&A Expenses 2.86% 6.56% 4.23% 5.58% 5.01%
Depreciation & Amortization 5.08% 11.68% 12.99% 19.36% 27.33%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 0.87% 0.49% -25.29% -12.80% -20.88%
Operating Income 59.14% 30.72% 39.09% -59.53% -70.88%
Income Before Tax 512.40% 658.32% -62.52% -118.28% -105.61%
Income Tax Expenses 66.82% 97.49% -346.67% -230.08% -153.54%
Earnings from Continuing Operations 3,208.66% 270.50% -59.02% -111.90% -100.87%
Earnings from Discontinued Operations 176.19% 173.33% -269.23% 90.00% -231.25%
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings 14.71% 20.51% 15.79% 36.17% 19.05%
Net Income 2,651.13% 279.00% -59.44% -112.09% -101.06%
EBIT 59.14% 30.72% 39.09% -59.53% -70.88%
EBITDA 38.38% 24.40% 30.87% -45.77% -58.70%
EPS Basic 2,595.87% 275.63% -59.80% -112.06% -101.08%
Normalized Basic EPS 41.51% 4.74% 15.07% -64.81% -72.72%
EPS Diluted 2,229.80% 297.64% -59.43% -112.44% -101.28%
Normalized Diluted EPS 41.50% 5.26% 16.96% -64.30% -72.34%
Average Basic Shares Outstanding 0.35% 0.37% 0.43% 0.51% 0.65%
Average Diluted Shares Outstanding 0.49% 0.30% -0.37% -0.94% -0.86%
Dividend Per Share 2.42% 2.44% 2.45% 2.47% 2.48%
Payout Ratio 1.04% -0.73% 1.54% -9.52% -97.92%